These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule. Sánchez-Murcia PA; Mills A; Cortés-Cabrera Á; Gago F J Comput Aided Mol Des; 2019 Jul; 33(7):627-644. PubMed ID: 31152293 [TBL] [Abstract][Full Text] [Related]
23. Interaction of a fluorescent derivative of paclitaxel (Taxol) with microtubules and tubulin-colchicine. Han Y; Chaudhary AG; Chordia MD; Sackett DL; Perez-Ramirez B; Kingston DG; Bane S Biochemistry; 1996 Nov; 35(45):14173-83. PubMed ID: 8916903 [TBL] [Abstract][Full Text] [Related]
24. Structural Basis of Microtubule Stabilization by Discodermolide. Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984 [TBL] [Abstract][Full Text] [Related]
25. 3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones. Manetti F; Forli S; Maccari L; Corelli F; Botta M Farmaco; 2003 May; 58(5):357-61. PubMed ID: 12729829 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype. Lopus M; Smiyun G; Miller H; Oroudjev E; Wilson L; Jordan MA Cancer Chemother Pharmacol; 2015 Nov; 76(5):1013-24. PubMed ID: 26416565 [TBL] [Abstract][Full Text] [Related]
27. Microtubule-Associated Protein Tau, α-Tubulin and βIII-Tubulin Expression in Breast Cancer. Im S; Yoo C; Jung JH; Jeon YW; Suh YJ; Lee YS; Choi HJ Korean J Pathol; 2013 Dec; 47(6):534-40. PubMed ID: 24421846 [TBL] [Abstract][Full Text] [Related]
29. Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers. Wang R; Wang H; Wang Z J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287508 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of microtubule stabilization by taccalonolide AJ. Wang Y; Yu Y; Li GB; Li SA; Wu C; Gigant B; Qin W; Chen H; Wu Y; Chen Q; Yang J Nat Commun; 2017 Jun; 8():15787. PubMed ID: 28585532 [TBL] [Abstract][Full Text] [Related]
31. Modulation of taxane binding to tubulin curved and straight conformations by systematic 3'N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potency. Ma Y; Josa-Prado F; Essif JN; Liu S; Li S; Lucena-Agell D; Chan PY; Goossens K; Hortigüela R; Matesanz R; Wang Y; Gago F; Wang H; Risinger A; Diaz JF; Fang WS Eur J Med Chem; 2023 Nov; 259():115668. PubMed ID: 37490800 [TBL] [Abstract][Full Text] [Related]
32. Structural basis of microtubule stabilization by laulimalide and peloruside A. Prota AE; Bargsten K; Northcote PT; Marsh M; Altmann KH; Miller JH; Díaz JF; Steinmetz MO Angew Chem Int Ed Engl; 2014 Feb; 53(6):1621-5. PubMed ID: 24470331 [TBL] [Abstract][Full Text] [Related]
33. Elucidating the mechanism of action of the clinically approved taxanes: a comprehensive comparison of local and allosteric effects. Churchill CD; Klobukowski M; Tuszynski JA Chem Biol Drug Des; 2015 Nov; 86(5):1253-66. PubMed ID: 26032329 [TBL] [Abstract][Full Text] [Related]
34. Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance. Nami B; Wang Z Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30126203 [TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells. Tripathi S; Srivastava G; Sharma A Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604 [TBL] [Abstract][Full Text] [Related]
36. BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling. Sung M; Giannakakou P Oncogene; 2014 Mar; 33(11):1418-28. PubMed ID: 23524581 [TBL] [Abstract][Full Text] [Related]
37. Relationship between the structures of taxane derivatives and their microtubule polymerization activity. Hidaka M; Koga T; Kiyota H; Horiguchi T; Shi QW; Hirose K; Uchida T Biosci Biotechnol Biochem; 2012; 76(2):349-52. PubMed ID: 22313785 [TBL] [Abstract][Full Text] [Related]
38. Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation. Prota AE; Setter J; Waight AB; Bargsten K; Murga J; Diaz JF; Steinmetz MO J Mol Biol; 2016 Jul; 428(15):2981-8. PubMed ID: 27395016 [TBL] [Abstract][Full Text] [Related]
39. Farnesyltransferase inhibitors reverse taxane resistance. Marcus AI; O'Brate AM; Buey RM; Zhou J; Thomas S; Khuri FR; Andreu JM; Díaz F; Giannakakou P Cancer Res; 2006 Sep; 66(17):8838-46. PubMed ID: 16951201 [TBL] [Abstract][Full Text] [Related]
40. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly. Hamel E; Day BW; Miller JH; Jung MK; Northcote PT; Ghosh AK; Curran DP; Cushman M; Nicolaou KC; Paterson I; Sorensen EJ Mol Pharmacol; 2006 Nov; 70(5):1555-64. PubMed ID: 16887932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]